Skip to content

Characterizing Bilateral Hypoglossal Nerve Stimulation During Drug-Induced Sleep Endoscopy

Characterizing Bilateral Hypoglossal Nerve Stimulation During Drug-Induced Sleep Endoscopy (BLISS - BiLateral Inspire Sedated Stimulation)

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06661629
Acronym
BLISS
Enrollment
0
Registered
2024-10-28
Start date
2024-12-20
Completion date
2025-11-13
Last updated
2026-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OSA - Obstructive Sleep Apnea

Brief summary

The study will investigate the treatment effect of bilateral genioglossus muscle stimulation on upper airway collapsibility during drug-induced sleep endoscopy in patients implanted with the Inspire hypoglossal nerve stimulator.

Interventions

The intervention is testing the effect of unilateral versus bilateral hypoglossal nerve stimulation on upper airway collapsibility during drug-induced sleep endoscopy

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (≥ 22yrs) willing and capable of providing informed consent * Implanted with the Inspire hypoglossal nerve stimulator

Exclusion criteria

* • Pregnant women\*

Design outcomes

Primary

MeasureTime frameDescription
Upper Airway Collapsability MeasuresDuring DISE - during the 20 minutes that the Drug Induced Sleep Endoscopy Occurs.PhOP - Pharangeal Opening Pressure, the minimum CPAP level needed to have an unobstructed airway

Secondary

MeasureTime frameDescription
Difference in Voltage RequirementsDuring DISE - During the 20 minutes during which the Drug Induced Sleep Endoscopy occursDifference in voltage between Inspire Device and External Stimulator during unilateral and bilateral stimulation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026